CHEMICALS · NSE/BSE: ANURAS

Anupam Rasayan India Limited Earnings Summary — Q1 FY2027

Sentiment: Neutral
AI-generated summary
Generated 2026-08-15
Generated using: Official Earnings Press Release
Business Intelligence Report

Anupam Rasayan Reports Strong Revenue Growth Led by Consolidated Segment as Subsidiaries Scale

Quarterly Business Intelligence

Q1 FY2027
Financials from Financial Intelligence · data as of 2026-06-30
Revenue
₹655 Cr
QoQ +3.0%YoY +34.8%
Net Profit
₹39 Cr
QoQ -9.4%YoY +13.5%
Operating Profit
₹162 Cr
QoQ +18.3%YoY +30.6%
Operating Margin
24.8%
QoQ +320 bpsYoY -79 bps

AI Quarterly Scorecard™

68
/ 100
Healthy
Revenue Momentum88
Profit Growth56
Margin Expansion64
Growth Consistency83
Operating Efficiency71
Financial Stability44

Computed deterministically from the last 10 reported quarters.

Quarterly Business Momentum

Revenue & Growth
  • Revenue has increased for 3 consecutive quarters.
  • Revenue of ₹655 Cr is 34.8% higher year-on-year.
  • Revenue has compounded at 24.4% annualised over the last 10 quarters.
Profitability
  • Net profit of ₹39 Cr is 13.5% above the same quarter last year.
  • Profit growth is trailing revenue growth this quarter.
  • Net profit has compounded at 10.4% annualised across the period.
Margins
  • Operating margin stands at 24.8% in Q1 FY2027.
  • Operating margin compressed by 79 bps year-on-year.
  • Over the last two years operating margin has expanded by 387 bps.
  • PBT margin is 10.6%.
Operating Efficiency
  • Expenses grew 36.3% against revenue growth of 34.8%.
  • Operating profit of ₹162 Cr is 30.6% higher year-on-year.
  • Operating leverage continues to improve.
Overall Momentum
  • 6 of the last 6 measured quarters delivered year-on-year revenue growth.
  • Overall quarterly business momentum scores 68/100 (Healthy) on the latest 10 quarters.
  • Business momentum remains positive heading into the next quarter.

Quarterly Financials

Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %

MetricTrend
Latest
Q1 FY2027
Q4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024
Revenue
Improving
655
636512731486500390294254401
Expenses
Improving
493
498385596362356266214201308
Operating Profit
Improving
162
137127136124144124805393
Operating Margin
Accelerating
24.8%
21.6%24.9%18.6%25.6%28.9%31.9%27.4%20.9%23.1%
Other Income
Volatile
13
32856-42612
Interest
Improving
49
423536363132272226
Depreciation
Strong Uptrend
56
433432313129222121
Profit Before Tax
Volatile
70
566076638859341658
Tax
Volatile
18
0-118142553417
Net Profit
Volatile
39
43494434452817431
Net Margin
Volatile
5.9%
6.7%9.6%6.1%7.0%8.9%7.2%5.7%1.5%7.7%
Source: Financial Intelligence (Structured Quarterly Data)Latest Quarter: Q1 FY2027Figures in ₹ Crore • Margins in %Automatically updated from Financial Intelligence · 2026-06-30

Key Takeaways

  • Consolidated revenue saw a robust 34.8% YoY growth, significantly outperforming standalone revenue growth of 4.15%.
  • Tanfac Industries Limited (Subsidiary) contributed strongly with ₹1,891.99 million in revenue and ₹168.49 million in net profit for the quarter.
  • Finance costs increased sharply to ₹491.92 million from ₹356.65 million YoY, reflecting rising debt servicing requirements.
  • The company appointed Mr. Ravi Desai as Chief Operating Officer (COO) effective August 14, 2026, to strengthen management.
  • Inventory adjustments (changes in finished goods/WIP) remained a significant factor, with a ₹691.99 million build-up this quarter.
  • Monitchem Kansas S.a.r.l was liquidated effective June 30, 2026, as part of corporate structure rationalization.

Management Guidance

Management continues to focus on commercializing flow chemistry at scale and leveraging its deep technical competency in multi-step synthesis for global Life Science giants.

Sentiment Shift

Stable

While top-line growth is very strong on a consolidated basis, margins and bottom-line growth are being tempered by high finance costs and depreciation from recent capital expansions.

Growth-oriented
Capital-intensive
Expansionary

Outlook

The outlook remains positive for revenue as recent capacity expansions (CWIP conversions) and subsidiary performances (Tanfac) kick in, though balance sheet deleveraging remains a key watchpoint for investors.

From the Annual Report (Key Quotes)

The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals.

Monitchem Kansas S.a.r.l has been Liquidated with effect from June 30, 2026.

Approved the appointment of Mr. Ravi Desai as Chief Operating Officer of the Company.

Official Quarterly Documents

Earnings Press Release
Official quarterly earnings release published by the company.
Download
Earnings Call Transcript
Management discussion and analyst Q&A.

Ask AI about this quarter

Sign in to ask AI questions grounded on the official earnings release and call transcript.

This summary is AI-generated from Anupam Rasayan India Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.

← Back to Anupam Rasayan India Limited AI analysis